Publication:

Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome. (1991)

Author(s): Hawdon JM, Ward Platt MP, Lamb WH, Aynsley-Green A.

    Abstract: An infant of 31 weeks' gestation presented with refractory neonatal hypoglycaemia secondary to islet cell dysregulation. Treatment was started with somatostatin analogue and his glycaemic control improved initially. Tolerance developed, however, in that the dose required to maintain control increased by a factor of 40. The infant subsequently underwent pancreatectomy. It is safe to use somatostatin analogue in a preterm infant, but tolerance to the drug rapidly develops.

      • Journal: Archives of Disease in Childhood
      • Volume: 66
      • Pages: 341-343
      • Publication type: Article
      • Bibliographic status: Published
      • PubMed id: 2025013
      Staff

      Dr Martin Ward Platt
      Honorary Clinical Reader in Neonatal and Paediatric Medicine